At a glance
ClinicalIndex Comparison RecordN/ACompleted· 23,026 enrolled
Drug / intervention
Primary Care Office Visitsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Substudy of Protocol NCT03843957: Effect of mPATH on Screening for Depression, Fall Risk, and Safety
In Brief
A clinical study evaluating Primary Care Office Visits for Depression. Completed, enrolled 23,026 participants across 1 site.
Detailed Summary
This is a sub-study for data analysis of data collected as part of the larger randomized controlled trial "Effectiveness and Implementation of mPATH-CRC" (NCT03843957) to determine if self-administered screening with an iPad increases the detection of patients with depression, falls, and intimate partner violence.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartJun 2019
Primary CompletionFeb 2020
First PostedNov 2021
TodayJul 2026
First PostedNov 5, 2021
Enrollment StartJun 24, 2019
Primary CompletionFeb 27, 2020
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.7 years ago
Interventions
Primary Care Office Visitsother
mPATH iPad program that contains self-administered screening items for depression, fall risk, and intimate partner violence